Press Releases
Addison’s Disease Treatment Market Latest Report with Forecast 2016 - 2024

, 26 March 2019 -- Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some individuals with Addison's disease. The need for treatment of Addison’s disease is growing due to rising prevalence of disease, increasing income in developed economies, and growing awareness. Furthermore, rising health expenditure is propelling the global market. Currently, the U.S. and EU5 countries are the key markets for Addison’s disease treatment, where the well-being of life with symptoms that are tough to manage have become controllable. The Addison’s disease treatment market is expected to expand at a high growth rate during the forecast period. Moreover, lack of proper diagnosis acts as a restraint of the market, especially in developing countries.

Read Report Overview:

Addison’s disease requires lifelong treatment with steroid replacement therapy. Glucocorticoid and mineralocorticoid replacement therapy is currently most widely used for the treatment of Addison's disease. Additional, hydrocortisone is one of the most preferred drugs belonging to the glucocorticoid class due to its short half-life which enables it to be quickly absorbed into the blood stream. Furthermore, long acting glucocorticoids such as dexamethasone and prednisone are beneficial for once daily dosing schedule. These do not replicate the physiological daily rhythm of endogenous cortisol production in the body, which results in excess glucocorticoid levels overnight. Rarely prescribed fludrocortisone belongs to the mineralocorticoid class and is frequently prescribed along with hydrocortisone.

The Addison’s disease treatment market can be segmented based on type of drug class, distribution channel, and region. In terms of drug class, the Addison’s disease treatment can be categorized into glucocorticoid and mineralocorticoid. Glucocorticoid can be categorized into hydrocortisone, dexamethasone, and prednisone. The mineralocorticoid segment can be sub-segmented into fludrocortisone. Based on distribution channel, the market can be segmented into hospital pharmacy, retail pharmacy, and e-commerce.

In terms of region, the Addison’s disease treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was the largest market for Addison’s disease treatment owing to high concerns for human health and growing awareness. Additionally, the U.S. and Canada have been successfully utilizing Addison’s disease treatment. This is likely to boost the growth of the market in the region. Presence of well-established health care infrastructure, government initiatives in implementing Addison’s disease treatment, and constantly improving reimbursement scenario is projected to propel the market in North America. Europe was the second largest market for Addison’s disease treatment owing to enhanced health processes and implementation of high health care concerns in the region.

Asia Pacific is expected to be the fastest growing market for Addison’s disease treatment. Major factors expected drive the Addison’s disease treatment market in the region are the large population and growing awareness about health, especially in India and China. Additionally, China and India are the top emerging markets in the region and would increasingly contribute to the growth of the Addison’s disease treatment. In Latin America, Brazil and Mexico are the countries that have significant potential for growth due to developing medical organization structure and rising disposable incomes.

Request Brochure of the Report:

Key players operating in the global Addison’s disease treatment market include Pfizer Inc., Boehringer Ingelheim GmbH, ViroPharma, Tocris Bioscience, GlaxoSmithKline plc, Merck KGaA, and Lupin Pharmaceuticals, Inc.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

# # #

Submitted by hawer on Tuesday, 26 March 2019 at 2:55 AM
Category: Health Care & Medical
Related News

Coronary Stents Market: Increase in Geriatric Population to Drive Demand
Friday, 19 Apr 2019

Wearable Medical Devices Market - Rising Number of Sports and Fitness Enthusiasts to Boost the Deman
Friday, 19 Apr 2019

Catheters Market - Increasing Demand for Minimally Invasive Surgeries to Spur the Demand
Friday, 19 Apr 2019

Fragment-based Drug Discovery Market Will be Worth US$1.15 bn by 2023
Friday, 19 Apr 2019

Homeopathy Product Market is Projected to be Worth US$17,486.2 mn by 2024
Friday, 19 Apr 2019

Related Events

The RAK International Psychiatry Congress
Friday, 19 Apr 2019

3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
Monday, 22 Apr 2019

Rx Drug Abuse and Heroin Summit
Monday, 22 Apr 2019

European NeoAg Summit 2019
Tuesday, 23 Apr 2019

Wednesday, 24 Apr 2019

Latest News

What to understand Just before Seeing a Foot Doctor
Saturday, 20 Apr 2019

What space is prescribed to purchase?
Saturday, 20 Apr 2019

Are Your Yorkie Dogs Shy and Timid?
Saturday, 20 Apr 2019

President of the Marshall Islands spent a long weekend on Bikendrik Island
Saturday, 20 Apr 2019

Tile and Grout Cleaning
Saturday, 20 Apr 2019

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Saturday, 20 April 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • The RAK International Psychiatry Congress
  • Palo Alto Networks: Palo Alto Networks Next Generation Firewall Hands-on Seminar
  • DOZ Live Inspirational Conference (DOZ Live)
  • 3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
  • Rx Drug Abuse and Heroin Summit

  • Latest Jobs
    Sorry, there are currently no entries posted here.